Name: Amantadine HCl
Pregnancy Category C
- Antiviral drug
- Antiparkinsonism drug
May inhibit penetration of influenza A virus into the host cell; may increase dopamine release in the nigostriatal pathway of parkinsonism patients, relieving their symptoms.
Prevention and treatment of influenza A virus respiratory infection, especially in high-risk patients
Adjunct to late vaccination against influenza A virus, to provide interim
coverage; supplement to vaccination in immunodeficient patients; prophylaxis
when vaccination is contraindicated
Parkinson's disease and drug-induced extrapyramidal reactions
Allergy to drug product, seizures, liverdisease, eczematoid rash, psychoses, CHF, renal disease, lactation.
- CNS: Lightheadedness, dizziness, insomnia, confusion, irritability, ataxia, psychosis, depression, hallucinations
- GI: Nausea, anorexia, constipation, dry mouth
- CV: CHF, orthostatic hypotension, dyspnea
- GU: Urinary retention
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community
Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.